Viewing nowCombinationRodienti Tablet 80/2.5mg (Telmisartan, Es-Amlodipine Nicotinic Acid Salt)
Telmisartan 80mg · S-Amlodipine Nicotinate 3.253mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 202104293 · Approved 2021.05.31 · Insurance code 645306560
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Es-Amlodipine or Telmisartan, effectively lowering and controlling blood pressure. It helps reduce the risk of cardiovascular complications and improves overall health through blood pressure management.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or 40mg of telmisartan. - 80/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or this medicine 40/2.5mg. - 40/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine). - 80/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine) or this medicine 40/5mg. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience (only for this medicine 40/2.5mg and 80/5mg). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual dosage regimen of S-amlodipine (amlodipine) is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Administration with caution in the following patients’). In elderly patients aged 75 years or older, clearance of S-amlodipine (amlodipine) is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious damage to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be used by women who are pregnant or may become pregnant. This medication is contraindicated in some patients, for example, in cases of allergy to its components or in severe liver disease, severe hypotension, heart shock, etc. Patients with certain conditions, such as primary aldosteronism, aortic stenosis, liver disease, gastrointestinal disease, kidney disease, and elderly individuals, should exercise special caution when using this medication. This medication may cause various side effects including dizziness, peripheral edema, palpitations, and hypotension, and in serious cases, fainting or heart problems may occur, so if any unusual symptoms appear, consult a doctor immediately. While taking this medication, it is essential to regularly monitor blood pressure, kidney function, and potassium levels to ensure no abnormalities. Drug interactions may occur when used in conjunction with other medications, so it is vital to inform your doctor or pharmacist of any current medications, particularly those that could be dangerous when used with this medication. Women who are pregnant or breastfeeding should not use this medication, and if pregnancy is planned or confirmed, they should immediately stop taking it and consult a healthcare professional. The safety and efficacy of this medication have not been adequately established in children under 18 years of age, hence its use is not recommended in this population. Elderly patients may respond more sensitively to this medication, so it is recommended to start at a lower dose and administer carefully. Overdosage may result in hypotension, dizziness, and arrhythmia; in such cases, it is necessary to visit a healthcare facility for appropriate treatment immediately. This medication should be stored out of reach of children, and transferring it to another container may lead to degradation of quality or accidents, so caution is advised.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air or moisture ingress. Additionally, it is recommended to keep the medication at a cool room temperature, ideally between 1 to 30 degrees Celsius.
Oval tablet consisting of light blue and white dual layers
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · S-Amlodipine Nicotinate 3.253mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Nicotinate 6.506mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Nicotinate 6.506mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Nicotinate 3.253mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.